MENU
+Compare
FXH
ETF ticker: NYSE ARCA
AS OF
May 22, 11:13 AM (EDT)
Price
$100.24
Change
-$0.56 (-0.56%)
Net Assets
921.91M

FXH stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index... Show more

Category: #Health
FXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for FXH with price predictions
May 21, 2025

Momentum Indicator for FXH turns positive, indicating new upward trend

FXH saw its Momentum Indicator move above the 0 level on May 15, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FXH just turned positive on April 23, 2025. Looking at past instances where FXH's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

FXH moved above its 50-day moving average on May 15, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FXH crossed bullishly above the 50-day moving average on May 19, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FXH advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 294 cases where FXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FXH broke above its upper Bollinger Band on May 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Medtronic plc (NYSE:MDT), Cigna Group (The) (NYSE:CI), ZOETIS (NYSE:ZTS).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Market Cap

The average market capitalization across the First Trust Health Care AlphaDEX® ETF ETF is 59.76B. The market cap for tickers in the group ranges from 2.19B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is APLS at 2.19B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Health Care AlphaDEX® ETF ETF was 11%. For the same ETF, the average monthly price growth was 40%, and the average quarterly price growth was 26%. SRPT experienced the highest price growth at 12%, while DOCS experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the First Trust Health Care AlphaDEX® ETF ETF was -22%. For the same stocks of the ETF, the average monthly volume growth was 17% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 66
Price Growth Rating: 53
SMR Rating: 100
Profit Risk Rating: 71
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
FXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
First Trust Exchange-Traded Alphadex Fd120 East Liberty Drive, Suite 400Wheaton
Phone
N/A
Web
www.ftportfolios.com